Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Journal for ImmunoTherapy of Cancer

Fig. 2

From: Chemo-immunotherapy improves long-term survival in a preclinical model of MMR-D-related cancer

Fig. 2

Treatment scheme. Mice received prophylactic or therapeutic applications of the vaccine, chemotherapy or a combination of both. The vaccine was prepared from an MLH1−/−-derived allograft. Immune monitoring as well as assessment of general behavior was done routinely during vaccination and at the experimental endpoint. Prior to therapy, mice underwent in vivo PET/CT imaging to confirm gastrointestinal tumorigenesis. Ex vivo analyses were done as described

Back to article page